Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Sarepta Therapeutics Inc shares valued at $248,203 were sold by Nicaise Claude on Mar 12 ’25. At $99.64 per share, Nicaise Claude sold 2,491 shares. The insider’s holdings dropped to 27,812 shares worth approximately $1.02 million following the completion of this transaction.
Also, Nicaise Claude purchased 2,491 shares, netting a total of over 248,226 in proceeds.
Before that, Wigzell Hans Lennart Rudolf had sold 10,500 shares from its account. In a trade valued at $1,310,820, the Director traded Sarepta Therapeutics Inc shares for $124.84 each. Upon closing the transaction, the insider’s holdings decreased to 10,500 shares, worth approximately $0.83 million.
As published in a research note from Evercore ISI on May 08, 2025, Sarepta Therapeutics Inc [SRPT] has been rated down from an Outperform to an In-line and the price target has been revised to $50. Analysts at Wells Fargo started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid April. As of April 02, 2025, H.C. Wainwright has increased its “Sell” rating to a “Neutral” for SRPT. Earlier on March 31, 2025, RBC Capital Mkts downgraded its rating. Their new recommendation was “a Sector perform” for SRPT stock which previously was a “an Outperform”.
Analyzing SRPT Stock Performance
During the last five days, there has been a drop of approximately -41.83%. Over the course of the year, Sarepta Therapeutics Inc shares have dropped approximately -69.96%. Shares of the company reached a 52-week high of $129.84 on 01/07/25 and a 52-week low of $35.46 on 05/08/25. A 50-day SMA is recorded $71.22, while a 200-day SMA reached $111.28.
Support And Resistance Levels for Sarepta Therapeutics Inc (SRPT)
According to the 24-hour chart, there is a support level at 35.31, which, if violated, would cause prices to drop to 34.10. In the upper region, resistance lies at 37.88. The next price resistance is at 39.24. RSI (Relative Strength Index) is 22.82 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -16.50, which suggests the price will decrease in the coming days. Percent R is at 96.39%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
